Brief: Prime Medicine Receives Up To $15 Million From Cystic Fibrosis Foundation To Advance Hotspot And PASSIGE Prime Editors For Cystic Fibrosis
25/01/2024 13:08
Jan 25 (Reuters) - Prime Medicine Inc PRME.O :
* PRIME MEDICINE RECEIVES UP TO $15 MILLION FROM CYSTIC
FIBROSIS
FOUNDATION TO ADVANCE HOTSPOT AND PASSIGE™ PRIME EDITORS FOR
CYSTIC FIBROSIS
Source text for Eikon: ID:nGNX6GN3MW
Further company coverage: PRME.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Prime Medicine
See all newsBrief: Prime Medicine Announces U.S. FDA Clearance Of Investigational New Drug Application For Pm647 In Alpha-1 Antitrypsin Deficiency
Prime Medicine, Inc. reports results for the quarter ended June 30 - Earnings Summary
Prime Medicine Q2 net loss narrows on lower expenses
Brief: Prime Medicine, Inc. Q2 EPS USD -0.24
Brief: Prime Medicine Announces U.S. FDA Clearance Of Investigational New Drug Application For Pm577a In H1069q-Mutated Wilson Disease